In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome
- 1 November 2014
- journal article
- research article
- Published by Elsevier BV in Reproductive BioMedicine Online
- Vol. 29 (5), 545-551
- https://doi.org/10.1016/j.rbmo.2014.07.019
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndromeFertility and Sterility, 2011
- Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndromePublished by Wiley ,2011
- Gonadotrophin-releasing hormone antagonists for assisted reproductive technologyPublished by Wiley ,2011
- Comparison of low-dose human menopausal gonadotropin and micronized 17β-estradiol supplementation in in vitro maturation cycles with thin endometrial liningFertility and Sterility, 2009
- The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled studyFertility and Sterility, 2008
- Obstetric Outcomes and Congenital Abnormalities After In Vitro Maturation, In Vitro Fertilization, and Intracytoplasmic Sperm InjectionObstetrics & Gynecology, 2007
- Gonadotrophin-releasing hormone antagonists for assisted conceptionPublished by Wiley ,2006
- The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected PopulationJournal of Clinical Endocrinology & Metabolism, 2004
- A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovariesObstetrics & Gynecology, 2002
- Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndromeHuman Reproduction, 2000